Alzaid, F. et al. showed a significant increase in IRF5 expression in hepatic macrophages of individuals with non-alcoholic fatty liver disease or hepatitis C virus infection, contributing to liver fibrosis. This evidence concerns the gene IRF5 and metabolic dysfunction-associated steatotic liver disease.